IC Surgical Inc

IC Surgical Inc is a medical technology company specializing in innovative surgical wound management solutions. The company manufactures the Interi® System, a proprietary internal surgical wound control platform designed to reduce post-operative complications, particularly seroma formation and fluid accumulation in surgically created tissue planes. The Interi System comprises three integrated components: the Interi Therapy Unit (a single-use, wearable device that generates continuous, consistent suction pressure for home or hospital use), the Interi Manifold (a patented multi-branched delivery mechanism that distributes suction pressure throughout closed internal surgical spaces via a single exit site), and the Manifold Connector (a one-way valve enabling safe device removal). Clinical evidence, including a 200-patient study published in Plastic & Reconstructive Surgery Global Open, demonstrates significant reduction in seroma incidence and other post-surgical complications compared to standard drain techniques. The technology represents a paradigm shift in deep-space wound healing by applying continuous negative pressure internally throughout tissue planes, eliminating dead space, and enabling continuous fluid removal. IC Surgical's products are indicated for use across multiple surgical specialties where internal wound management and complication reduction are priorities, including plastic and reconstructive surgery. The company maintains peer-reviewed publications documenting improved clinical outcomes and maintains focus on both hospital and home-care deployment models.